DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Cardiology Homepage

MaxQ-AI seeks $8 million public IPO listing on Nasdaq Will help FDA regulatory processes for Accipio software products

Boston Scientific to buy VENITI for $160 million Price may rise pending FDA approval of Vici Venous Stent

NIH grants $1.5 million to Magnetic Insight for development of new imaging modality Uses non-radioactive, iron oxide nanoparticle tracer

Boston Scientific to acquire TAVR protection system with purchase of Claret Medical Will acquire ownership of the Sentinel System

Viz.ai to extend LVO AI-based platform beyond stroke Using $21 million from Series A funding to do so

Fewer ICDs are failing to comply with CMS NCD standards, says study Follows DOJ investigation into overuse of non-NCD-compliant ICDs

DaVita hit with $383.5 million jury verdict in dialysis death suit Three patients suffered cardiac arrest after getting GranuFlo therapy

New research finds leadless pacemakers cause fewer complications than conventional option Will they become the new standard?

Cardioverter defibrillator vest may be viable alternative to pediatric implants Promising study results may help patients unfit for surgery

Ivor Benjamin American Heart Association seats new president and officers as chairman enters 2nd of two-year term

Abbott's directional Infinity DBS
system now features MR-conditional
labeling

MR-conditional labeling now available for Abbotts Infinity DBS system

by John R. Fischer , Staff Reporter
Patients implanted with Abbott’s directional Infinity DBS system can now look forward to MR exams with less anxiety with a new software upgrade cleared by the FDA that provides the solution with MR-conditional labeling.

The addition of the over-the-air software upgrade makes the solution the first and only FDA-cleared MR-conditional directional DBS system on the market, enhancing safety and access for necessary MR procedures among patients with Parkinson’s disease, essential tremor and other movement disorders.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



“MR-conditional labeling offers peace of mind to patients who may need a scan in the future,” Dr. Binith Cheeran, medical director of movement disorders at Abbott, told HCB News. “It allows centers that do intraoperative MR scans during DBS surgery to offer this advanced therapy to patients with Parkinson’s disease. An upgradeable platform allows us to bring enhancements like MR-conditional labeling to patients who have already had a directional Infinity DBS system.”

The potential need for future MR exams has made providers hesitant to offer patients advanced DBS therapy options for comfort and treatment, out of concern for their safety.

Transmitted through secure Bluetooth wireless technology, the upgrade equips patients implanted with existing Infinity DBS systems with full-body MR-conditional labeling, eliminating the need for surgical intervention.

Clearance for providing MR-conditional labeling is an endeavor that Abbott has worked for and secured in several of its products, including its Resynchronization Therapy Defibrillator (CRT-D) and Fortify Assura Implantable Cardioverter Defibrillator (ICD) solutions earlier this year. It also added MR-conditional labeling last September to its Ellipse ICD.

In addition, the upgrade also provides programming tools and expands field-shaping simulation options available to Infinity DBS users.

“A good analogy for this is a Tesla versus a traditional car. On a traditional car, like older DBS platforms, the car you buy is the car you live with. Abbott’s Infinity system is more like a Tesla,” said Cheeran. “You buy the car and add significant enhancements through over-the-air updates as required. Abbott’s Infinity DBS platform allows us to add therapy enhancements that can help maintain a patient’s ability to live the life they want to, for longer, in the face of progressive disease.”

Back to HCB News
  Pages: 1

Cardiology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED